- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 233/76 - Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
Patent holdings for IPC class C07D 233/76
Total number of patents in this class: 80
10-year publication summary
|
2
|
9
|
3
|
9
|
4
|
5
|
3
|
7
|
2
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Autifony Therapeutics Limited | 50 |
5 |
| King Faisal University | 931 |
5 |
| Evonik Operations GmbH | 4320 |
5 |
| Buck Institute for Research on Aging | 129 |
4 |
| Oxiscience Wa, LLC | 10 |
4 |
| Bristol-myers Squibb Company | 4721 |
2 |
| The Regents of the University of California | 20669 |
2 |
| Evonik Degussa GmbH | 1389 |
2 |
| Board of Regents of the University of Nebraska | 795 |
2 |
| Elanco US Inc. | 717 |
2 |
| The Glad Products Company | 483 |
2 |
| Monash University | 734 |
2 |
| Schering Corporation | 352 |
2 |
| Swiss Tropical and Public Health Institute | 10 |
2 |
| Allergan, Inc. | 2181 |
1 |
| Bayer AG | 3487 |
1 |
| Huawei Technologies Co., Ltd. | 122474 |
1 |
| DSM IP Assets B.V. | 5392 |
1 |
| Abbvie Inc. | 1838 |
1 |
| Arkema France | 4225 |
1 |
| Other owners | 33 |